Participants will be randomized to drug or placebo for 12 months
Most satisfied members highlight Calibrates structure and accountability as game changers, while unhappy members say the process feels too slow, strict, or poorly managed
A meta-analysis of 80 000 patients found GLP-1 RAs were not associated with an increased risk of optic nerve/vision-threatening events [11], and a recent clinical trial of people taking the highest dose of semaglutide demonstrated excellent safety, increased muscle strength and an increased ratio of lean mass relative to total body mass in people taking semaglutide [12]
When to Seek Medical Advice About Skin Changes Whilst most skin changes during GLP-1 therapy are benign and cosmetic, certain presentations warrant prompt medical evaluation
How IV Therapy May Support a Weight-Loss Plan Used well, IV support can make the hard parts of fat loss a little easier, keeping you hydrated, steady on energy, and able to recover so you can follow your plan
